Sanofi Consumer Healthcare India’s Q2 FY25 profit surged 109% YoY to Rs 60.7 crore, driven by exports and new launches.

• Revenue grew 28% YoY and 27.5% QoQ to Rs 220.9 crore, fueled by product relaunches and international expansion.
• Net cash flow from operations fell sharply to Rs 17.9 crore in H1, down from Rs 231.5 crore last year.
• Key launches included Allegra D, Depura 60k, and Combiflam Suspension, supporting growth in allergy and pain relief categories.